Page 29 - Multiple System Atrophy News Today

/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying...

Amprion has announced the commercial rollout of its innovative SYNTap Biomarker Test, a first-in-class laboratory-developed test (LDT) for accurate...

San Francisco, CA (PRWEB) October 06, 2021 -- Amprion has announced the commercial rollout of its innovative SYNTap Biomarker Test, a first-in-class

People with rapid eye movement (REM) sleep behavior disorder act out their dreams. While sleeping safely in bed, for example, they might throw up their arms to catch an imaginary ball, or try to run from an illusory assailant.

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics to...

McLean, VA (PRWEB) October 01, 2021 -- The Multiple System Atrophy (“MSA”) Coalition announces a ground-breaking million-dollar multi-year collaborative

MCLEAN Va. (PRWEB) October 01 2021 The Multiple System Atrophy (“MSA”) Coalition announces a ground-breaking million-dollar multi-year collaborative project focused,The,Multiple,System,Atrophy,Coalition,Announces,a,Groundbreaking,Project,to,Explore,the,Genetics,of,MSA,medicine,advanced medical technology,medical laboratory technology,medical device technology,latest medical technology,Health

Potential new treatments for Parkinson's disease developed by researchers at Rush University Medical Center have shown success in slowing progression of the disease in mice.

How a patient who couldn’t swallow or stand made a dramatic turnaround

How a patient who couldn’t swallow or stand made a dramatic turnaround